PBS NewsHour

WATCH: Trump announces Pfizer deal to lower drug prices

Newsweek

What Is ‘TrumpRx’? White House Unveils New Prescription Drug Website

Breitbart

Jeffries Decries Trump AI Sombrero Video as ‘Bigotry’

Trump to announce deal with Pfizer to lower drug prices

Business Insider

Trump announces 'TrumpRx' website alongside Pfizer CEO

Daily Caller

Trump Unveils Initiative To Claw Back Runaway Drug Prices

Pfizer to lower some drug prices as White House builds "TrumpRX" website

New York Post

White House unveils ‘TrumpRX’ drug-buying website, announces Pfizer lowering prices in US

Axios

Pfizer Trump Deal Drug Companies

CNBC

Trump, Pfizer agree to lower U.S. drug prices, exempt company from pharma tariffs

Donald Trump

Trump 2024 Election Promises

President Trump announced Tuesday that Pfizer agreed to provide prescription medications to Medicaid at most-favored-nation prices, matching the lowest prices offered in other developed nations, while the company will invest $70 billion in U.S. manufacturing.</span

The Wall Street Journal

Trump White House

President Trump announced Tuesday that Pfizer agreed to provide prescription medications to Medicaid at most-favored-nation prices, matching the lowest prices offered in other developed nations, while the company will invest $70 billion in U.S. manufacturing.

The Trump administration will launch a government-operated website called TrumpRx by early 2026, allowing consumers to purchase discounted prescription drugs directly from manufacturers with savings ranging from 40% to 85% on select medications.</span

USA Today

The Trump administration will launch a government-operated website called TrumpRx by early 2026, allowing consumers to purchase discounted prescription drugs directly from manufacturers with savings ranging from 40% to 85% on select medications.

Pfizer's agreement with the White House caused significant reaction within the pharmaceutical industry, as the company's CEO Albert Bourla serves as board chair of PhRMA, putting pressure on other drugmakers to negotiate similar deals.</span

Pfizer's agreement with the White House caused significant reaction within the pharmaceutical industry, as the company's CEO Albert Bourla serves as board chair of PhRMA, putting pressure on other drugmakers to negotiate similar deals.

Under the agreement, Pfizer receives a three-year grace period from pharmaceutical tariffs in exchange for domestic manufacturing investments, while Trump threatened 100% tariffs on companies that don't build U.S. facilities.</span

Under the agreement, Pfizer receives a three-year grace period from pharmaceutical tariffs in exchange for domestic manufacturing investments, while Trump threatened 100% tariffs on companies that don't build U.S. facilities.

The deal includes specific drug discounts such as Eucrisa at 80% off for dermatitis treatment, Xeljanz at 40% off for rheumatoid arthritis, and Zavzpret at 50% off for migraines when purchased directly by patients.</span

The deal includes specific drug discounts such as Eucrisa at 80% off for dermatitis treatment, Xeljanz at 40% off for rheumatoid arthritis, and Zavzpret at 50% off for migraines when purchased directly by patients.

Trump stated that Americans pay more than three times the price for brand-name drugs compared to other developed nations, with the U.S. funding roughly 75% of global pharmaceutical profits despite having less than 5% of world population.</span

Trump stated that Americans pay more than three times the price for brand-name drugs compared to other developed nations, with the U.S. funding roughly 75% of global pharmaceutical profits despite having less than 5% of world population.

PBS NewsHour #1

Newsweek #1

Breitbart #1

NBC #1

Business Insider #1

Daily Caller #1

CBS #1

New York Post #1

Axios #0

CNBC #0

The Wall Street Journal #

Trump White House #

Business Insider #2527

USA Today #

Daily Caller #5426

Axios #

New York Post #4090

CNBC #

Newsweek #3053

PBS NewsHour #4126

CBS #2785

Trump Announces Pfizer Deal for Lower Drug Prices, $70B Investment

Trump Announces Pfizer Deal for Lower Drug Prices, $70B Investment

Trump Announces Pfizer Deal for Lower Drug Prices, $70B Investment

The Controversies

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Trump Announces Pfizer Deal for Lower Drug Prices, $70B Investment

Trump Announces Pfizer Deal for Lower Drug Prices, $70B Investment

The Controversies

Articles on this story

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters